Cargando…
Methylation of PAX1 gene promoter in the prediction of concurrent chemo-radiotherapy efficacy in cervical cancer
Objectives: Cervical cancer is the fourth leading cause of cancer death among women worldwide. In currently, aberrant methylation of PAX1 is found in variety of solid tumors, including cervical cancer. In addition, the role of PAX1 gene methylation in cervical cancer and precancerous lesions screeni...
Autores principales: | Li, Xuanxuan, Zhou, Xue., Zeng, Manting, Zhou, Yangying, Zhang, Yu, Liou, Yu-Ligh, Zhu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317535/ https://www.ncbi.nlm.nih.gov/pubmed/34335930 http://dx.doi.org/10.7150/jca.57460 |
Ejemplares similares
-
PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer
por: Li, Xuanxuan, et al.
Publicado: (2023) -
Real-time colorimetric detection of DNA methylation of the PAX1 gene in cervical scrapings for cervical cancer screening with thiol-labeled PCR primers and gold nanoparticles
por: Huang, Jin, et al.
Publicado: (2016) -
DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma
por: Huang, Jin, et al.
Publicado: (2017) -
The promising role of PAX1 (aliases: HUP48, OFC2) gene methylation in cancer screening
por: Fang, Chao, et al.
Publicado: (2019) -
Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging
por: Zhu, Li, et al.
Publicado: (2016)